Suraksha Diagnostics, a leading healthcare provider specializing in diagnostic services, has announced an initial public offering (IPO) as part of its fund raising for business expansion and other corporate purposes. Suraksha Diagnostic IPO will commence on November 29, 2024 and close on December 3, 2024. Suraksha Diagnostic IPO will be a bookbuilt offering. The company plans to raise approximately INR 846.25 Crore through the IPO, consisting of a fresh issue of INR [.] million through an offer for sale of up to 1,918,9330 ordinary shares of face value of INR 2 each. Here we provide a detailed breakdown of all you need to know about Suraksha Diagnostics IPO including date, price band, GMP, expert reviews, etc.
Suraksha Diagnostics IPO Date
The Suraksha Diagnostics IPO will be open for subscription soon. The key dates to note are:
IPO Opening Date: Friday, November 29, 2024
IPO Closing Date: Tuesday, December 3, 2024
Basic of Allotment Date: Wednesday, December 4, 2024
Listing Date: Friday, December 6, 2024
Investors can apply for the IPO during this window, after which the allotment process will begin.
Suraksha Diagnostics IPO Price Band
The company has set the price band for the IPO, which will determine the cost per share for investors:
Price Band: Rs.420 to Rs.441 per share
Lot Size: 34 Shares (The minimum number of shares you can apply for)
The price range is crucial for retail investors, and depending on the demand, the final price will be decided closer to the listing date. The IPO is likely to attract attention due to its strong growth potential in the healthcare space.
Suraksha Diagnostics IPO GMP
The Grey Market Premium (GMP) gives an indication of the investor interest in the IPO. It reflects the price at which the shares are likely to list on the stock exchange on the listing day. While GMP can fluctuate daily, a high GMP often indicates strong demand for the issue.
Suraksha Diagnostics IPO - Financials and Use of Proceeds
Suraksha Diagnostics is a well-established name in the diagnostic sector. The company plans to use the funds raised through this IPO for several key purposes:
Expansion of existing diagnostic centers.
Upgrading technology and infrastructure.
General corporate purposes.
The financial health of the company is strong, with a steady growth trajectory in terms of revenue and profit. It has an established customer base and a well-regarded brand in the diagnostic sector.
Suraksha Diagnostics IPO - Company Overview
Suraksha Diagnostics is a leader in the diagnostic healthcare industry, offering a range of services such as laboratory testing, imaging, pathology, and other diagnostic solutions. The company has seen significant growth in recent years, fueled by the increasing demand for diagnostic services and the growing awareness of preventive healthcare.
Sector: Healthcare/Diagnostics
Promoters: The company is backed by a seasoned management team with decades of experience in healthcare and diagnostics.
Suraksha Diagnostics IPO - Key Strengths
Established Brand: Suraksha Diagnostics is a trusted name in the healthcare sector, which gives it an edge over new entrants in the market.
Strong Growth Potential: The healthcare industry in India is rapidly growing, and the demand for diagnostic services is increasing exponentially due to changing lifestyles and rising health concerns.
Quality of Service: The company has a reputation for providing high-quality and accurate diagnostic tests, which has helped it build a loyal customer base.
Expanding Network: Suraksha Diagnostics is continuously expanding its network of centers, which will help it tap into more markets and increase its revenue potential.
Suraksha Diagnostics IPO - By Expert Investor Review
From an investor perspective, Suraksha Diagnostics` IPO represents an interesting opportunity, especially for investors looking to invest in the growing healthcare and diagnostics sector. The company`s strong reputation, expanding network and focus on quality service make it a promising player in the space.
Conclusion
Suraksha Diagnostics` IPO could be a great opportunity for long-term investors looking to capitalize on the growth of India`s healthcare sector. However, as with any investment, it`s important to conduct thorough research, weigh the risks, and assess whether the stock is priced attractively.
2024(16)
